Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W D Perry

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|January 6, 2025
How to Design an Inhaled Drug: CHF-6523Matthew W D Perry
Pharmacological Research|October 14, 2020
14-3-3 modulation of the inflammatory responseClaire C Munier, Christian Ottmann, Matthew W D Perry
Bioorganic & Medicinal Chemistry Letters|May 15, 2022
Surprising lipophilicity observations identify unexpected conformational effectsMatthew W D Perry, Ulf Börjesson, Antonios Nikitidis, et al.
The Journal of Organic Chemistry|October 25, 2003
[3 + 2] cycloaddition reactions of 4-alkyl-3-hydroxy-2H-pyrazolo[4,3-c]isoquinolinium inner saltsEifion D Phillips, Simon C Hirst, Matthew W D Perry, et al.
Nature Reviews. Drug Discovery|June 15, 2021
PI3K inhibitors are finally coming of ageBart Vanhaesebroeck, Matthew W D Perry, Jennifer R Brown, et al.
Nature Reviews. Drug Discovery|March 30, 2026
A renaissance in targeting the PI3K/AKT/mTOR pathwaySarah E Conduit, Neil Vasan, Jennifer R Brown, et al.
Organic Letters|September 6, 2012
Spiro-fused pyrrolidine, piperidine, and oxindole scaffolds from lactamsChristoph Hirschhäuser, Jeremy S Parker, Matthew W D Perry, et al.
Drug Discovery Today|October 5, 2014
Designing novel building blocks is an overlooked strategy to improve compound qualityFrederick W Goldberg, Jason G Kettle, Thierry Kogej, et al.
Chemmedchem|April 11, 2009
A practical method for targeted library design balancing lead-like properties with diversityMichael J Stocks, Gareth R H Wilden, Garry Pairaudeau, et al.
Journal of Medicinal Chemistry|December 6, 2019
Design, Synthesis, and Biological Evaluation of MEK PROTACsStefan Vollmer, Danen Cunoosamy, Huafei Lv, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|January 6, 2025
How to Design an Inhaled Drug: CHF-6523Matthew W D Perry
Pharmacological Research|October 14, 2020
14-3-3 modulation of the inflammatory responseClaire C Munier, Christian Ottmann, Matthew W D Perry
Bioorganic & Medicinal Chemistry Letters|May 15, 2022
Surprising lipophilicity observations identify unexpected conformational effectsMatthew W D Perry, Ulf Börjesson, Antonios Nikitidis, et al.
The Journal of Organic Chemistry|October 25, 2003
[3 + 2] cycloaddition reactions of 4-alkyl-3-hydroxy-2H-pyrazolo[4,3-c]isoquinolinium inner saltsEifion D Phillips, Simon C Hirst, Matthew W D Perry, et al.
Nature Reviews. Drug Discovery|June 15, 2021
PI3K inhibitors are finally coming of ageBart Vanhaesebroeck, Matthew W D Perry, Jennifer R Brown, et al.
Nature Reviews. Drug Discovery|March 30, 2026
A renaissance in targeting the PI3K/AKT/mTOR pathwaySarah E Conduit, Neil Vasan, Jennifer R Brown, et al.
Organic Letters|September 6, 2012
Spiro-fused pyrrolidine, piperidine, and oxindole scaffolds from lactamsChristoph Hirschhäuser, Jeremy S Parker, Matthew W D Perry, et al.
Drug Discovery Today|October 5, 2014
Designing novel building blocks is an overlooked strategy to improve compound qualityFrederick W Goldberg, Jason G Kettle, Thierry Kogej, et al.
Chemmedchem|April 11, 2009
A practical method for targeted library design balancing lead-like properties with diversityMichael J Stocks, Gareth R H Wilden, Garry Pairaudeau, et al.
Journal of Medicinal Chemistry|December 6, 2019
Design, Synthesis, and Biological Evaluation of MEK PROTACsStefan Vollmer, Danen Cunoosamy, Huafei Lv, et al.
Pageof 3